BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 29959729)

  • 1. A Genome-Wide Association Study of α-Synuclein Levels in Cerebrospinal Fluid.
    Zhong XL; Li JQ; Sun L; Li YQ; Wang HF; Cao XP; Tan CC; Wang L; Tan L; Yu JT;
    Neurotox Res; 2019 Jan; 35(1):41-48. PubMed ID: 29959729
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The relevance of cerebrospinal fluid α-synuclein levels to sporadic and familial Alzheimer's disease.
    Twohig D; Rodriguez-Vieitez E; Sando SB; Berge G; Lauridsen C; Møller I; Grøntvedt GR; Bråthen G; Patra K; Bu G; Benzinger TLS; Karch CM; Fagan A; Morris JC; Bateman RJ; Nordberg A; White LR; Nielsen HM;
    Acta Neuropathol Commun; 2018 Nov; 6(1):130. PubMed ID: 30477568
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genome-wide association study identifies
    Chen J; Yu JT; Wojta K; Wang HF; Zetterberg H; Blennow K; Yokoyama JS; Weiner MW; Kramer JH; Rosen H; Miller BL; Coppola G; Boxer AL;
    Neurology; 2017 Feb; 88(7):669-676. PubMed ID: 28100725
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Longitudinal Study of Total and Phosphorylated α-Synuclein with Other Biomarkers in Cerebrospinal Fluid of Alzheimer's Disease and Mild Cognitive Impairment.
    Wang H; Stewart T; Toledo JB; Ginghina C; Tang L; Atik A; Aro P; Shaw LM; Trojanowski JQ; Galasko DR; Edland S; Jensen PH; Shi M; Zhang J;
    J Alzheimers Dis; 2018; 61(4):1541-1553. PubMed ID: 29376878
    [TBL] [Abstract][Full Text] [Related]  

  • 5. α-Synuclein in cerebrospinal fluid of Alzheimer's disease and mild cognitive impairment.
    Korff A; Liu C; Ginghina C; Shi M; Zhang J;
    J Alzheimers Dis; 2013; 36(4):679-88. PubMed ID: 23603399
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cerebrospinal fluid α-synuclein and Lewy body-like symptoms in normal controls, mild cognitive impairment, and Alzheimer's disease.
    Mackin RS; Insel P; Zhang J; Mohlenhoff B; Galasko D; Weiner M; Mattsson N
    J Alzheimers Dis; 2015; 43(3):1007-16. PubMed ID: 25125463
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genome-wide association study identified ATP6V1H locus influencing cerebrospinal fluid BACE activity.
    Hu H; Li H; Li J; Yu J; Tan L;
    BMC Med Genet; 2018 May; 19(1):75. PubMed ID: 29751835
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genome-wide association reveals genetic effects on human Aβ42 and τ protein levels in cerebrospinal fluids: a case control study.
    Han MR; Schellenberg GD; Wang LS;
    BMC Neurol; 2010 Oct; 10():90. PubMed ID: 20932310
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genome-wide association study of CSF biomarkers Abeta1-42, t-tau, and p-tau181p in the ADNI cohort.
    Kim S; Swaminathan S; Shen L; Risacher SL; Nho K; Foroud T; Shaw LM; Trojanowski JQ; Potkin SG; Huentelman MJ; Craig DW; DeChairo BM; Aisen PS; Petersen RC; Weiner MW; Saykin AJ;
    Neurology; 2011 Jan; 76(1):69-79. PubMed ID: 21123754
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cerebrospinal fluid α-synuclein predicts neurodegeneration and clinical progression in non-demented elders.
    Li JQ; Bi YL; Shen XN; Wang HF; Xu W; Tan CC; Dong Q; Wang YJ; Tan L; Yu JT;
    Transl Neurodegener; 2020 Nov; 9(1):41. PubMed ID: 33228804
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genome-wide association study identifies four novel loci associated with Alzheimer's endophenotypes and disease modifiers.
    Deming Y; Li Z; Kapoor M; Harari O; Del-Aguila JL; Black K; Carrell D; Cai Y; Fernandez MV; Budde J; Ma S; Saef B; Howells B; Huang KL; Bertelsen S; Fagan AM; Holtzman DM; Morris JC; Kim S; Saykin AJ; De Jager PL; Albert M; Moghekar A; O'Brien R; Riemenschneider M; Petersen RC; Blennow K; Zetterberg H; Minthon L; Van Deerlin VM; Lee VM; Shaw LM; Trojanowski JQ; Schellenberg G; Haines JL; Mayeux R; Pericak-Vance MA; Farrer LA; Peskind ER; Li G; Di Narzo AF; ; ; Kauwe JS; Goate AM; Cruchaga C
    Acta Neuropathol; 2017 May; 133(5):839-856. PubMed ID: 28247064
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genome-wide association study identifies
    Li X; Chu SG; Shen XN; Hou XH; Xu W; Ou YN; Dong Q; Tan L; Yu JT
    Aging (Albany NY); 2019 Nov; 11(21):9862-9874. PubMed ID: 31711042
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of cerebrospinal fluid α-synuclein with total and phospho-tau
    Vergallo A; Bun RS; Toschi N; Baldacci F; Zetterberg H; Blennow K; Cavedo E; Lamari F; Habert MO; Dubois B; Floris R; Garaci F; Lista S; Hampel H; ;
    Alzheimers Dement; 2018 Dec; 14(12):1623-1631. PubMed ID: 30055132
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Associations of sleep characteristics with alpha-synuclein in cerebrospinal fluid in older adults.
    Wang XT; Liu FT; Bi YL; Shen XN; Xu W; Wang J; Tan L; Yu JT
    Ann Clin Transl Neurol; 2020 Oct; 7(10):2026-2034. PubMed ID: 32949229
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genome-wide association study identifies two loci influencing plasma neurofilament light levels.
    Li JQ; Yuan XZ; Li HY; Cao XP; Yu JT; Tan L; Chen WA;
    BMC Med Genomics; 2018 May; 11(1):47. PubMed ID: 29747637
    [TBL] [Abstract][Full Text] [Related]  

  • 16. α-Synuclein species as potential cerebrospinal fluid biomarkers for dementia with lewy bodies.
    van Steenoven I; Majbour NK; Vaikath NN; Berendse HW; van der Flier WM; van de Berg WDJ; Teunissen CE; Lemstra AW; El-Agnaf OMA
    Mov Disord; 2018 Nov; 33(11):1724-1733. PubMed ID: 30440090
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of CR1 Genetic Variants on Cerebrospinal Fluid and Neuroimaging Biomarkers in Healthy, Mild Cognitive Impairment and Alzheimer's Disease Cohorts.
    Zhu XC; Wang HF; Jiang T; Lu H; Tan MS; Tan CC; Tan L; Tan L; Yu JT;
    Mol Neurobiol; 2017 Jan; 54(1):551-562. PubMed ID: 26742530
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cerebrospinal fluid levels of alpha-synuclein, amyloid β, tau, phosphorylated tau, and neuron-specific enolase in patients with Parkinson's disease, dementia with Lewy bodies or other neurological disorders: Their relationships with cognition and nuclear medicine imaging findings.
    Katayama T; Sawada J; Kikuchi-Takeguchi S; Kano K; Takahashi K; Saito T; Okizaki A; Hasebe N
    Neurosci Lett; 2020 Jan; 715():134564. PubMed ID: 31733322
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genome-wide association study of CSF levels of 59 alzheimer's disease candidate proteins: significant associations with proteins involved in amyloid processing and inflammation.
    Kauwe JS; Bailey MH; Ridge PG; Perry R; Wadsworth ME; Hoyt KL; Staley LA; Karch CM; Harari O; Cruchaga C; Ainscough BJ; Bales K; Pickering EH; Bertelsen S; ; Fagan AM; Holtzman DM; Morris JC; Goate AM
    PLoS Genet; 2014 Oct; 10(10):e1004758. PubMed ID: 25340798
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genome-wide association and interaction studies of CSF T-tau/Aβ
    Li J; Zhang Q; Chen F; Meng X; Liu W; Chen D; Yan J; Kim S; Wang L; Feng W; Saykin AJ; Liang H; Shen L;
    Neurobiol Aging; 2017 Sep; 57():247.e1-247.e8. PubMed ID: 28641921
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.